Breaking News Instant updates and real-time market news.

MSFT

Microsoft

$115.14

-0.46 (-0.40%)

16:33
10/02/18
10/02
16:33
10/02/18
16:33

Microsoft unveils Surface Laptop 2

At a company event, Microsoft announced the Surface Laptop 2, the latest in the company's line of laptops. The device comes with omnisonic speakers and an alcantara covered keyboard, and is 85% faster than the previous version of the device. Reference Link

  • 16

    Oct

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

MSFT Microsoft
$115.14

-0.46 (-0.40%)

09/24/18
09/24/18
DOWNGRADE

Negative
Nutanix downgraded to Negative from Neutral at Susquehanna
As previously reported, Susquehanna analyst Mehdi Hosseini downgraded Nutanix to Negative from Neutral and reduced his price target on shares to $33 from $55. The analyst believes Nutanix's OEM relationships are likely to become "less impactful over time," and also cited increasing competition as a headwind. Hosseini specifically said not to count out Microsoft (MSFT), noted that VMware (VMW) continues to add new features for vSAN while tightening integration with AWS, and expects an IPO from Dell in the coming months.
09/27/18
OPCO
09/27/18
NO CHANGE
Target $127
OPCO
Outperform
Microsoft to drive digital transformations through hybrid cloud,says Oppenheimer
After attending Microsoft Ignite, Oppenheimer anakyst Timothy Horan says adoption of hybrid cloud is accelerating, enabling three areas of growth with enterprises, namely upgrading legacy IT, adoption of cloud Infrastructure as a Service through Azure, and new services. The company had hundreds of announcements including a new cloud service and a virtual desktop, which highlights its optimism on its networking/cloud capabilities, he contends. Horan reiterates an Outperform rating and $127 price target on the shares.
09/27/18
JMPS
09/27/18
NO CHANGE
JMPS
JMP says battle lines drawn with Salesforce on one side, Microsoft on other
After attending Salesforce's (CRM) analyst day hosted in conjunction with the Dreamforce user conference, Patrick Walravens noted that the event "happens to coincide" with Microsoft's (MSFT) Ignite conference in Orlando. He said the most interesting new development in the competitive landscape is the way the "battle lines are being drawn" between Salesforce, Google (GOOGL) and Amazon (AMZN), which announced new strategic relationships this week, and Microsoft, SAP (SAP) and Adobe (ADBE), who announced the Open Data Initiative on September 24, on the other side. In terms of product highlights from Dreamforce, Chief Product Officer Bret Taylor highlighted Customer 360 and Einstein Voice, said Walravens, who keeps an Outperform rating and $178 price target on Salesforce shares.
10/02/18
NOMU
10/02/18
DOWNGRADE
Target $63
NOMU
Reduce
Nomura downgrades MongoDB to Reduce on 'extreme valuation'
Nomura Instinet Christopher Eberle downgraded MongoDB (MDB) to Reduce from Neutral while raising his price target for the shares to $63 from $43. The stock closed yesterday at $78.86. The company's current market value reflects "extreme valuation," Eberle tells investors in a research note. MongoDB has a "compelling" multi-year, if not multi-decade, opportunity, but it faces "intense competition and deep-pocketed incumbency that won't die easily," the analyst contends. He points out that in the last year alone, Microsoft's (MSFT) Cosmos DB grew from zero to $100M revenue. Eberle believes the current market price of MongoDB assumes no risks.

TODAY'S FREE FLY STORIES

YARIY

Yara

$0.00

(0.00%)

07:17
10/19/18
10/19
07:17
10/19/18
07:17
Upgrade
Yara rating change  »

Yara upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOLVY

Volvo

$0.00

(0.00%)

07:17
10/19/18
10/19
07:17
10/19/18
07:17
Periodicals
Volvo CEO says doesn't expect fine from emissions probe, Bloomberg says »

Volvo CEO says emissions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASB

Associated Banc-Corp

07:17
10/19/18
10/19
07:17
10/19/18
07:17
Downgrade
Associated Banc-Corp rating change  »

Associated Banc-Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

AXP

American Express

$102.86

-1.53 (-1.47%)

07:16
10/19/18
10/19
07:16
10/19/18
07:16
Recommendations
American Express analyst commentary  »

Oppenheimer remains a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

ECYT

Endocyte

$23.40

7.85 (50.48%)

, NVS

Novartis

$86.24

0.9 (1.05%)

07:16
10/19/18
10/19
07:16
10/19/18
07:16
Downgrade
Endocyte, Novartis rating change  »

Endocyte downgraded to…

ECYT

Endocyte

$23.40

7.85 (50.48%)

NVS

Novartis

$86.24

0.9 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

07:15
10/19/18
10/19
07:15
10/19/18
07:15
General news
Oil Action: Front-month WTI crude prices are up 0.7% »

Oil Action: Front-month…

AVXL

Anavex

$2.47

0.015 (0.61%)

07:14
10/19/18
10/19
07:14
10/19/18
07:14
Hot Stocks
Anavex receives FDA approval of IND for Phase 2 trial of Anavex 2-73 »

Anavex announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$40.37

-1.29 (-3.10%)

07:14
10/19/18
10/19
07:14
10/19/18
07:14
Downgrade
Harley-Davidson rating change  »

Harley-Davidson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

WMT

Walmart

$96.19

-0.37 (-0.38%)

07:13
10/19/18
10/19
07:13
10/19/18
07:13
Recommendations
Walmart analyst commentary  »

Oppenheimer more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 15

    Nov

CTSH

Cognizant

$73.60

-0.4 (-0.54%)

07:13
10/19/18
10/19
07:13
10/19/18
07:13
Recommendations
Cognizant analyst commentary  »

Cognizant risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 30

    Oct

  • 02

    Nov

  • 16

    Nov

QSR

Restaurant Brands

$57.16

0.08 (0.14%)

07:12
10/19/18
10/19
07:12
10/19/18
07:12
Recommendations
Restaurant Brands analyst commentary  »

Restaurant Brands'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

IBKC

Iberiabank

$75.27

-2.65 (-3.40%)

07:11
10/19/18
10/19
07:11
10/19/18
07:11
Hot Stocks
Iberiabank sees FY19 average earning assets $28.6B-$28.9B »

Sees FY19 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

VLRX

Valeritas

$1.22

-0.04 (-3.17%)

07:10
10/19/18
10/19
07:10
10/19/18
07:10
Hot Stocks
Valeritas announces launch of V-Go in Italy »

Valeritas announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

PGTI

PGT Innovations

$21.93

-0.33 (-1.48%)

07:10
10/19/18
10/19
07:10
10/19/18
07:10
Initiation
PGT Innovations initiated  »

PGT Innovations initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

07:10
10/19/18
10/19
07:10
10/19/18
07:10
General news
Canada retail sales preview »

Canada retail sales…

07:10
10/19/18
10/19
07:10
10/19/18
07:10
General news
Canada CPI preview »

Canada CPI preview:…

MYGN

Myriad Genetics

$44.61

0.18 (0.41%)

07:09
10/19/18
10/19
07:09
10/19/18
07:09
Hot Stocks
Myriad Genetics announces new data on Vectra test for RA treatment »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

KBAL

Kimball International

$15.93

-0.27 (-1.67%)

07:08
10/19/18
10/19
07:08
10/19/18
07:08
Hot Stocks
Kimball International to acquire David Edward for $4.85M »

Kimball, a subsidiary of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

VFC

VF Corp.

$87.07

-2.22 (-2.49%)

07:08
10/19/18
10/19
07:08
10/19/18
07:08
Hot Stocks
VF Corp. CEO says Q2 results 'were strong driven by our core brands' »

"VF's second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

PYPL

PayPal

$77.50

-2.61 (-3.26%)

, V

Visa

$139.32

-3.1 (-2.18%)

07:08
10/19/18
10/19
07:08
10/19/18
07:08
Recommendations
PayPal, Visa, MasterCard analyst commentary  »

PayPal price target…

PYPL

PayPal

$77.50

-2.61 (-3.26%)

V

Visa

$139.32

-3.1 (-2.18%)

MA

MasterCard

$203.81

-3.58 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 30

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

  • 29

    Jan

PG

Procter & Gamble

$80.31

-0.8628 (-1.06%)

07:07
10/19/18
10/19
07:07
10/19/18
07:07
Earnings
Procter & Gamble sees FY19 core EPS up 3%-8%, consensus $4.37 »

P&G said it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 03

    Mar

LIVX

LiveXLive Media

$2.95

-0.13 (-4.22%)

07:07
10/19/18
10/19
07:07
10/19/18
07:07
Initiation
LiveXLive Media initiated  »

LiveXLive Media initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

RMTI

Rockwell Medical

$4.26

-0.09 (-2.07%)

07:06
10/19/18
10/19
07:06
10/19/18
07:06
Downgrade
Rockwell Medical rating change  »

Rockwell Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLRX

BioLineRx

$1.20

-0.24 (-16.67%)

, MRK

Merck

$72.22

0.42 (0.58%)

07:06
10/19/18
10/19
07:06
10/19/18
07:06
Hot Stocks
BioLineRx presents top-line Phase 2a results of pancreatic cancer combination »

BioLineRx (BLRX)…

BLRX

BioLineRx

$1.20

-0.24 (-16.67%)

MRK

Merck

$72.22

0.42 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

REGN

Regeneron

$395.39

-3.29 (-0.83%)

, SNY

Sanofi

$44.45

-0.24 (-0.54%)

07:06
10/19/18
10/19
07:06
10/19/18
07:06
Hot Stocks
Regeneron, Sanofi Kevzara data to provide additional insight on efficacy in RA »

Regeneron Pharmaceuticals…

REGN

Regeneron

$395.39

-3.29 (-0.83%)

SNY

Sanofi

$44.45

-0.24 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.